Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × INDUSTRY × Goserelin × Clear all

Phase

Status

Completed 32 Terminated 7 Recruiting 3 Withdrawn 2 Unknown 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Injections 34 Carboplatin 27 Docetaxel 23 Oxaliplatin 22 Capecitabine 21 pembrolizumab 20 Paclitaxel 20 Cisplatin 19 Gemcitabine 16 Bevacizumab 16 Pemetrexed 14 Cyclophosphamide 12 Fluorouracil 11 tislelizumab 9 Leucovorin 9 Irinotecan 9 Drug Therapy 9 osimertinib 8 Doxorubicin 7 fludarabine 6 Trastuzumab 6 Nivolumab 6 palbociclib 5 lenvatinib 5 Topotecan 5 Prednisolone 5 Fulvestrant 5 Dexamethasone 5 130-nm albumin-bound paclitaxel 5 toripalimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07287098 2026-03-16

preEMBER

Eli Lilly and Company

Phase 2 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡